Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world
  • Posted by Julie Denny
  • April 29, 2016
  • News

Promotions and new appointments across our global offices

Promotions and new appointments across our global offices

Research Partnership is delighted to announce promotions and new starters in the UK and further appointments in the US and Singapore offices

Paul Reed, who has over 10 years experience in Market Research, has recently been promoted to Director in recognition of the significant role he has played in the expansion of the Emerging Markets team and contribution to their strong growth. Paul consistently performs to a very high standard and is recognised as an excellent researcher and a solid team leader by both project members and clients. Jamie Laidlaw has been promoted to Research Manager. Jamie joined the company 3 years ago as a graduate and has quickly developed into a strong and capable researcher, recognised for his project management, analytical skills and professional client interaction.

read more »

Are biosimilars the answer to the rising cost of RA treatment?

Are biosimilars the answer to the rising cost of RA treatment?

Our latest Free Thinking white paper explores why the uptake of Biosimilars has been slower than expected and asks what's next for RA?

Monoclonal-antibody (mAb) biologics have significantly improved treatment options and outcomes in rheumatoid arthritis (RA), particularly where patients do not respond to conventional disease-modifying anti-rheumatics.
The burden of disease from RA, including the cost of treatment, additional care and loss of productivity, is considerable. With disease onset peaking at 55 to 64 years, this burden will increase as populations age worldwide, aggravated by rising obesity and other characteristics of unhealthy lifestyles. Therapeutic mAbs, are helping to ease that load. As with most biologics, however, they come at a substantial cost.
In a past Free Thinking paper, we looked at the opportunity and challenges for biosimilar mAbs entering the rheumatoid arthritis market. A few years later and according to our Therapy Watch patient record data, uptake of biosimilars remains relatively muted, with marked inconsistencies across the major European markets. With Enbrel biosimilar Benepali about to launch across EU, we ask what’s next for RA?

read more »

  • Posted by Julie Denny
  • April 28, 2016
  • Videos

Storytelling in healthcare market research

Within the pharmaceutical industry, there is an increasing need for market research teams to share the insights with their key internal stakeholders, from marketing and brand managers to sales reps and senior management. These audiences don’t have the time to review long Powerpoint presentations created by the market research agency. They demand short, engaging outputs which tell the insight story. In this video Marketing Director Julie Denny explores how the art of storytelling can be applied to healthcare market research and outlines some of the  data visualisation tools which Research Partnership employs to present the story which clients can share with their key stakeholders.

read more »

  • Posted by Julie Denny
  • April 18, 2016
  • Events

BHBIA Annual Conference 2016

BHBIA Annual Conference 2016

9-10 May 2016, London

Research Partnership is delighted to be attending and presenting one of the conference training sessions at the BHBIA Annual 2016 in May. Representing Research Partnership is Associate Director Will Tolley who will present the course ‘Demand Assessments: Research to Reflect the Real-World Environment’ on the first day of the two day event.

read more »

  • Posted by Julie Denny
  • April 15, 2016
  • Articles

Forever Angels achievements and development plan for 2016

Forever Angels achievements and development plan for 2016

Research Partnership is proud to support Forever Angels in their mission of caring for and improving the lives of orphans and abandoned infants in Tanzania.

Forever Angels have recently released their strategic plan for 2016, in which they share the history of the charity and how it started, the challenges that they have overcome and future plans so they can continue to help improve the lives of Children in need in Tanzania.
Amy Hathaway opened the baby home in 2006, and for years built up the home, taking in and caring for hundreds of young children. Amy moved back to the UK in 2014, where she continues to oversee all marketing for the charity. The home is now under careful management of Josephine and Lillian and is in a good position to sustainably continue its work. They have a strong team of 63 Tanzanian staff, who are supported by a number of various volunteers from around the world. Since the baby home opened back in 2006, Forever Angels have taken in 297 children, returned 138 to relatives, helped 64 children be adopted into loving families and assisted the community care for a further 250 babies a fantastic 10 year achievement. 

read more »